U.S. jury fails to reach verdict in latest J&J talc
trial
Send a link to a friend
[May 26, 2018]
By Tina Bellon
NEW YORK (Reuters) - A South Carolina jury
on Friday could not agree on a verdict in a case of a woman whose family
said her long-term use of Johnson & Johnson's Baby Powder led to her
death from asbestos-related cancer, resulting in a mistrial.
The case of Bertila Boyd-Bostic, who died of a rare form of cancer in
2017 at the age of 30, is the latest in a series of trials in the United
States that center around allegations that the company's talc-based
powder contained asbestos.
"We're disappointed the jury did not reach a unanimous verdict for
Johnson & Johnson," the company said in a statement emailed to Reuters.
"The talc in Johnson's Baby Powder does not contain asbestos, which is
supported by more than 50 years of independent, non-litigation driven
scientific evaluations."
Asbestos is a known carcinogen linked to mesothelioma, the type of
cancer Boyd-Bostic had been diagnosed with at the age of 29.
After two weeks of trial, the jury in the Darlington County Court of
Common Pleas said it could not decide whether J&J was responsible for
the disease. Under South Carolina law, a jury has to make a unanimous
decision.
Christopher Swett, a lawyer for the family of Boyd-Bostic, said in a
statement that the plaintiffs would retry the case at the earliest
opportunity.
"We continue to believe that the daily use of baby powder on Bertila
from birth led to her death," Swett said.
The case also named as a defendant the U.S. unit of talc supplier Imerys
SA, as well as a local unit of Rite Aid, one of the largest U.S.
drugstore chains, which allegedly sold the baby powder used by the
woman.
[to top of second column] |
A Johnson & Johnson building is shown in Irvine, California, U.S.,
January 24, 2017. REUTERS/Mike Blake
Gwen Myers, a spokeswoman for Imerys Talc America, said: "We remain confident
that talc does not cause cancer. Imerys follows all FDA and other regulatory
guidelines and utilizes rigorous testing to ensure that our talc meets the
highest quality standards. We continue to stand by the safety of our product."
Rite Aid did not immediately respond to a request for comment.
J&J is battling some 9,000 cases claiming its talc products cause ovarian
cancer, but litigants have recently focused on claims based on alleged asbestos
contamination.
A California jury on Thursday awarded $25.7 million in damages to a woman and
her husband over allegations that the company's baby powder had caused her
mesothelioma.
A New Jersey court jury in April ordered J&J and Imerys Talc America to pay $117
million to a man who alleged he developed mesothelioma due to asbestos exposure
from talc-based products.
The company won the only other asbestos-related trial in November, when a Los
Angeles Superior Court jury ruled in its favor.
(Reporting by Tina Bellon, Editing by Rosalba O'Brien and Diane Craft)
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|